OD
Oh, D-y.
1 papers · 4 citations · 2025–2025
Publications
1
Citations
4
Years
1
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Event-free survival (EFS) and patient-reported outcomes (PROs) in MATTERHORN: A randomised, phase III study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) chemotherapy in resectable gastric/ gastroesophageal junction (G/GEJ) adenocarcinoma
|
2025 | Meeting Abstract | 4 |